Announcements Trials
Browse Landscape

Status

Recruiting 8Unknown 6Completed 5Terminated 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1CNS 1

Conditions

Solid Tumor 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Glioma 1Ependymoma 1

Interventions

Observation 23Blood Specimen Collection 20Drug Therapy 14Surveys and Questionnaires 10Surgical Procedures, Operative 8Immune Checkpoint Inhibitors 8Immunotherapy 7Positron Emission Tomography Computed Tomography 5Hematologic Tests 5Watchful Waiting 4Neoadjuvant Therapy 4Fluorodeoxyglucose F18 4Bevacizumab 4tislelizumab 3envafolimab 3darolutamide 3Tyrosine Kinase Inhibitors 3Therapeutics 3Standard of Care 3Radiotherapy 3Letrozole 3Indocyanine Green 3Imatinib Mesylate 3Endosonography 3Endoscopic Mucosal Resection 3Docetaxel 3Cyclophosphamide 3Capecitabine 3Artificial Intelligence 3pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × Histocompatibility Testing × Clear all
NCT06895681 2026-05-04

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

University of California, San Francisco

Not yet recruiting
50,000 enrolled
Other solid neoplasm

Solid Tumor

NCT06323408 2025-03-25

BZKF-AYA

University Hospital Regensburg

Not yet recruiting
72 enrolled
CNS

Ependymoma, Glioma, Medulloblastoma, Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡